hicn medic news part  cut limit azt efficaci suggest use drug either sequenti drug kind aid treatment cocktail combin number drug fight viru treat peopl azt alon happen real world anymor said dr mark jacobson univers california san francisco also recent find indic hiv replic rapidli lymph node infect physician may begin push even harder earli treatment hiv infect patient   new infecti diseas push american medic news vol p  center diseas control launch worldwid network track spread infecti diseas detect drug resist new strain time help prevent spread network expect cost million million essenti part clinton administr health reform plan accord cdc outsid expert plan requir cdc enhanc surveil diseas unit state establish facil across world track diseas   april   nih plan begin aid drug trial earlier stage natur vol p macilwain colin   hicnet medic newslett page volum number april  nation institut health announc start treat hiv posit patient soon possibl seroconvers result recent find show hiv activ bodi larg number much earlier previous believ anthoni fauci director u nation institut allergi infecti diseas niaid said must address question treat peopl earli possibl drug safe enough give peopl year get around microbi resist said delay would signifi question safeti resist rather lack fund fauci co author one two paper publish last week natur reject argument one co author cecil fox new discoveri indic billion spent vaccin trial wast time money trial start long patient infect end quickli john tew medic colleg virginia richmond claim new evid strongli back argument earli treatment hiv infect patient aid activist welcom new inform said scientif commun slow understand signific infect lymph tissu known five year glad public domain said jess dobson california base project inform peter duesberg believ aid independ hiv result drug abus west said sever paradox away explan aid even paper right   april   risk aid viru doctor found minim washington post p  risk hiv transmit infect health care profession patient minim accord new research publish today journal american medic associ jama find support previou conclus health expert chanc contract hiv health care worker remot three studi jama demonstr thousand patient treat two hiv posit surgeon dentist without becom infect viru studi conduct separ research team new hampshir maryland florida studi start hiv posit doctor dentist test patient particip new hampshir studi found none patient undergon invas procedur hiv posit orthoped surgeon contract hiv maryland patient oper breast surgeri specialist john hopkin hospit found hiv neg similarli florida dental  hicnet medic newslett page volum number april  patient treat hiv posit gener dentist test found neg hiv florida research led gordon dickinson univers miami school medicin said studi indic risk transmiss hiv gener dentist patient minim set univers precaut strictli observ relat stori philadelphia inquir p  altern medicin advoc divid new nih research program aid treatment news p gilden dave  new offic altern medicin nation institut health rais question nih commit effort use unorthodox holist therapeut method oam small divis nih budget million dollar compar billion nih whole addit money avail research grant even smaller total avail year grant kaiya montaocean center natur tradit medicin washington c say oam afraid becom involv aid look success easi answer aid said also common percept oam focu field nih establish find non threaten relax techniqu acupunctur oam call advisori committe confer peopl last year aid commun larg miss meet addit activist gener lack contact offic ad suspicion epidem ignor jon greenberg act new york said oam advisori panel compos practition without real research experi take sever year accept natur research nevertheless dr leanna standish research director aid investig bastyr colleg naturopath medicin seattl said wonder opportun fund aid research fair give offic time gel public insist much much public relat  herpesviru decim immun cell soldier scienc news vol p fackelmann kathi  scientist conduct test tube experi found herpesviru attack human immun system natur killer cell attack caus killer cell malfunct diminish import compon immun system fight diseas also herpesviru may factor immun diseas aid paolo lusso research found herpesviru attack anoth white cell cd lymphocyt primari target hiv lusso also found herpesviru  hicnet medic newslett page volum number april  kill natur killer cell scientist previous knew natur killer cell patient infect hiv work correctli lusso research repres first time scientist indic natur killer cell vulner kind viral attack accord anthoni l komaroff research harvard medic school despit test tube find scientist uncertain whether result occur bodi lusso team also found herpesviru produc cd receptor molecul provid access hiv cd lymphocyt express surfac receptor make vulner hiv attack research conclud herpesviru cell exacerb affect hiv   april   aid prioriti global villag editor journal american medic associ vol p gellert georg nordenberg dale f  health care worker oblig respons ensur politician understand dimens certain health problem also commit relat polici write georg gellert dale f nordenberg orang counti health care agenc santa ana calif emori univers school public health atlanta ga respect dr berkley editori american doctor care aid epidem beyond unit state detail sever reason concert interest countri share combat aid note aid lead hasten global health interdepend ill diseas malaria mani respiratori intestin pathogen similarli inhibit econom develop human act margin larg popul berkley mention enorm social econom impact aid mani develop countri increas need intern assist result berkley also cite lack polit aggress toward aid epidem first decad new administr promis substanti differ approach intern health develop gener hiv aid particular vice presid al gore propos book earth balanc major environment initi includ sustain intern develop program promot literaci improv child surviv dissemin contracept technolog access throughout develop world enact chang polici could drastic chang futur worldwid health  aid prioriti global villag repli journal american  hicnet medic newslett page volum number april  medic associ vol p berkley seth  everi nation tackl hiv earli aggress possibl diseas reach endem state even cost divert le attent ill write seth berkley rockefel foundat new york n repli letter dr gellert nordenberg although true diseas aid malaria respiratori intestin ill similarli inhibit econom develop develop countri deserv much attent get berkley disagre content aid receiv much attent hiv differ diseas develop countri continu spread endem diseas outcom neglect intervent one year anoth year level needle diseas death aid increas spread cost neglect diseas burden financi much greater intervent earli part rampantli spread epidem like hiv highli cost effect individu infect prevent significantli interrupt transmiss berkley say agre gellert nordenberg gigant social econom effect aid need polit leadership conclud assert polit leadership need unit state aid epidem even develop countri high rate hiv infect complac epidem rule                      hicnet medic newslett page volum number april     aid hiv articl   first hiv vaccin trial begin hiv infect child h h n e w  u depart health human servic march   first hiv vaccin therapi trial begin hiv infect child   nation institut health open first trial experiment hiv vaccin child infect human immunodefici viru hiv viru caus aid  trial compar safeti three hiv experiment vaccin child recruit least site nationwid volunt must hiv infect symptom hiv diseas  hh secretari donna e shalala said initi studi seen hope mileston effort amelior tragedi hiv infect child face certainti develop aid  anthoni fauci director nation institut allergi infecti diseas nih offic aid research said trial first step find whether vaccin help prevent delay diseas progress child hiv yet sick vaccin prove safe sophist question therapeut potenti ass phase ii trial  center diseas control prevent estim child unit state hiv end decad world health organ project million child infect worldwid  studi enrol child age month year old niaid fund aid clinic trial group network anticip conduct trial nine actg site around countri three site particip actg fund nation institut child health human develop  preliminari evid similar studi way infect adult show certain vaccin boost exist hiv specif immun respons  hicnet medic newslett page volum number april  stimul new one sever year howev research know respons affect clinic cours diseas  result pediatr trial known actg examin close reason well trial provid first insight immatur immun system respond candid hiv vaccin said daniel hoth director niaid divis aid need inform design trial test whether experiment vaccin prevent hiv infect child  unit state hiv infect child live poor inner citi area percent minor mainli black hispan  nearli hiv infect child acquir viru mother pregnanc birth infect mother unit state one four chanc transmit viru babi grow number woman childbear age becom expo hiv inject drug use infect sexual partner research expect correspond increas number infect child  hiv diseas progress rapidli infant child adult recent inform suggest percent infant born hiv develop seriou aid relat infect year age infect includ sever frequent bout common bacteri ill childhood result seizur pneumonia diarrhea symptom lead nutrit problem long hospit stay  least half child trial year age younger enabl comparison immun respons younger older particip volunt must well document hiv infect symptom hiv diseas swollen lymph gland mildli swollen liver spleen receiv anti retrovir immun regul drug within one month prior entri studi  studi chair john lambert univers rochest medic school co chair samuel katz duke univers school medicin coordin trial assist jame mcnamara medic offic pediatr medicin branch niaid divis aid  compar safeti vaccin close monitor child side effect see one vaccin produc swollen arm fever exampl anoth said dr mcnamara also look whether low high dose vaccin stimul immun respons signific laboratori clinic effect emphas small studi size preclud compar respons effect among three  hicnet medic newslett page volum number april  product  trial test two dose three experiment vaccin made recombin hiv protein call subunit vaccin genet engin contain piec viru far prove well toler ongo trial hiv infect adult  one vaccin made microgenesi inc meriden conn contain gp protein give rise hiv surfac protein plu alum adjuv adjuv boost specif immun respons vaccin present alum adjuv use human vaccin licens food drug administr  vaccin one made genentech inc south san francisco biocin joint ventur chiron ciba geigi emeryvil calif contain major hiv surfac protein gp plu adjuv genentech vaccin contain alum biocin vaccin contain mf experiment adjuv prove safe effect phase vaccin trial adult  low dose product test first placebo child twelv child assign random immun experiment vaccin three child given adjuv alon consid placebo neither health care worker child told receiv  low dose well toler control test higher dose experiment vaccin adjuv placebo anoth group child begin  child receiv six immun one everi four week six month follow week last immun  inform trial site elig enrol call aid clinic trial inform servic trial p est weekday servic spanish speak inform specialist avail inform niaid pediatr hiv aid research avail offic commun  nih cdc fda agenc u public health servic hh press inquiri plea call lauri k doepel     hicnet medic newslett page volum number april  new evid hiv caus diseas independ news nation institut dental research  new evid human immunodefici viru caus diseas independ abil suppress immun system say scientist nation institu health  report hiv opportunist infect caus scale skin condit develop mouse carri gene hiv although hiv gene activ mouse compromis anim immun research found led conclud hiv caus skin diseas  find support grow bodi evid hiv caus diseas without affect immun system said lead author dr jeffrey kopp nation institut dental research nidr dr kopp colleagu describ studi march issu aid research human retrovirus  develop anim model hiv infect difficult sinc anim includ mouse infect viru bypass problem scientist develop hiv transgen mouse carri gene hiv well genet materi  nidr scientist creat transgen mouse inject hiv gene mous egg implant egg femal mouse result litter contain normal transgen anim  institut scientist creat mouse carri complet copi hiv genet materi l mouse howev becam sick die soon birth studi depth present studi scientist use incomplet copi hiv allow anim live longer  transgen anim develop scale wart like tumor neck back transgen mouse develop thicken crust skin lesion cover bodi resembl psoriasi human skin lesion develop normal non transgen litterm  studi tissu taken wart like skin tumor show type noncancer tumor call papilloma although papillomaviru caus skin lesion laboratori test show sign viru anim  tissu sampl taken sick mouse throughout studi reveal presenc protein produc molecul made hiv genet materi  hicnet medic newslett page volum number april  evid hiv protein product prove viral gene turn activ said dr kopp  scientist found evid howev compromis immun mouse increas white blood cell count sign common infect fact hiv gene activ anim immun system suppress confirm viru caus skin lesion dr kopp said  proof hiv gene involv came test scientist expo transgen anim ultraviolet light light increas hiv genet activ caus papilloma develop formerli healthi skin papilloma format respons increas hiv genet activ prove gene respons skin condit scientist said lesion appear normal mouse expo uv light  transgen mouse use studi develop nidr dr peter dicki nation institut allergi infecti diseas  collabor studi dr kopp mr charl wohlenberg dr nickola dorfman joseph bryant abner notkin paul klotman nidr dr stephen katz nation cancer institut dr jame rooney formerli nidr burrough wellcom                      hicnet medic newslett page volum number april  clinic consult telephon servic aid h h n e w  u depart health human servic  march   hh secretari donna e shalala today announc first nationwid clinic consult telephon servic doctor health care profession question provid care peopl hiv infect aid toll free nation hiv telephon consult servic staf physician nurs practition pharmacist provid inform drug clinic trial latest treatment method servic fund health resourc servic administr oper san francisco gener hospit secretari shalala said one goal project share expertis patient get best care second goal get primari health care provid involv care peopl hiv aid reduc treatment cost allow patient remain medic provid commun social support network current mani provid refer patient hiv aid specialist provid experi secretari shalala said clinic expertis especi help physician provid treat peopl hiv aid commun clinic site hiv expertis readili avail telephon number health care profession access p est p pst monday friday time consult tri answer question immedi within hour time physician health care provid leav electron messag question answer quickli possibl health care profession may call servic ask question relat provid hiv care includ latest hiv aid drug treatment inform clinic trial inform subspecialti case referr literatur search inform servic design health care profession rather patient famili altern sourc inform materi health care profession call new servic call taken either clinic pharmacist primari care physician famili nurs practition staff member extens experi outpati inpati primari care peopl hiv relat diseas consult ask patient specif inform includ cd cell count current medic sex age patient hiv histori nation servic grown month local effort  hicnet medic newslett page volum number april  respond nearli call health care provid northern california initi project fund hrsa bureau health profess commun provid aid train cpat project american academi famili physician provid expand knowledg also improv qualiti care abl provid patient said hrsa administr robert g harmon p h project great resourc health care profession hiv aid patient serv servic open new mean commun health care profession expert hiv care manag said hrsa associ administr aid director bureau health resourc develop g stephen bowen p h provid treat peopl hiv aid access latest inform new drug treatment method therapi peopl hiv aid hrsa one eight u public health servic agenc within hh   aid hotlin number consum  cdc nation aid hotlin aid inform spanish sida aid clinic trial english spanish trial                        hicnet medic newslett page  cut last part   